This novel research suggests that psilocybin, a psychoactive compound in magic mushrooms, may be effective in treating body dysmorphic disorder (BDD), enhancing brain connectivity.
Conducted by a U.S., Canadian, and Swedish team, the study is significant as it reports brain changes after psilocybin administration in BDD patients, highlighting its potential.
Previous treatments for BDD often proved ineffective; however, participants demonstrated improved symptoms with a single 25-milligram dose of psilocybin, suggesting new therapeutic avenues.
With brain imaging revealing increased activity between executive functions and emotional stimuli, this research supports psilocybin's role in addressing complex mental health challenges.
Collection
[
|
...
]